The American pharmaceutical company Pfizer reported that in the first quarter of this year it recorded net profits of US$ 3,115 million, 44% less than in the same period of 2023. While the company’s billing reached US$ 14,879 million, a reduction of 20% in interannual terms. According to the New York-based pharmaceutical giant, the drop […]
Tag: Pfizer
Science is on the eve of a renaissance thanks to AI, according to Pfizer
The science is on the eve of entering a period of “rebirth” gthanks to the artificial intelligencewhich accelerates research and allows for faster results, said today the CEO of the pharmaceutical company PfizerAlbert Bourla. “I truly believe that we are about to enter a scientific renaissance in the life sciences due to the coexistence of […]
Pfizer will modify anti-obesity tablet after negative results
A new drug against obesity developed by Pfizer caused a high rate of side effects during a clinical trial that will therefore not continue, the American pharmaceutical giant announced. Pfizer He specified, however, that he will work on a modified version of the drug, called danuglipron. That medicine belongs to a new class of successful […]
The European regulator approves a new anti-covid vaccine adapted from Pfizer
The European Medicines Agency (EMA) approved on Wednesday an adapted version of the anti-Covid vaccine from Pfizer et BioNTech to combat infection by a widespread subvariant of the virus in winter. Although since the beginning of May the World Health Organization no longer considers Covid-19 a global health emergency, the virus continues to circulate in […]
The US accuses a Pfizer employee of using inside information to gain on the stock market
The Securities Market Commission of USA denounced this Thursday, June 29, a former employee of the pharmaceutical company Pfizer for allegedly using privileged information about the pill against the COVID-19 to multiply your stock market gains. According to a statement, Amit Dagarone of the statisticians in the clinical trial of the Paxlovid drughe learned that […]
FDA contradicts Pfizer on second cycle of Paxlovid for COVID
There is not “any evidence” that a second course of Paxlovid from Pfizer Inc. will help COVID-19 patients whose symptoms return after an initial course of the antiviral, a Food and Drug Administration (FDA) official said. from the United States a day after Pfizer executives defended the idea. Doctors and virologists have been struggling to […]
Generic drugmakers to produce cheap version of Pfizer’s COVID pill
Thirty-five generic drugmakers around the world will produce cheap versions of Paxlovid, Pfizer Inc’s highly effective oral antiviral for COVID-19, to supply the treatment in 95 poor countries, the Medicines Patent Pool (MPP) reported. backed by the UN. Pfizer struck a deal with the group last year to allow generic manufacturers to make the pills […]
Pfizer asks the US to authorize fourth dose of anti-COVID vaccine
Updated on 03/15/2022 08:44 pm Pfizer and its partner BioNTech on Tuesday asked US regulators to authorize an additional booster dose of its COVID-19 vaccine for seniors, saying data from Israel indicates older adults would benefit. Nowadays, United States recommends two initial injections followed by a booster dose for everyone 12 years of age and […]
Pfizer affirms that a fourth dose of the vaccine against COVID-19 is necessary
Updated on 03/14/2022 10:40 am In order to have greater protection against COVID-19 and its variants, the CEO of Pfizer, Albert Bourlanoted during an interview last Sunday that people will need a fourth dose of the vaccine. “A fourth (dose) booster is needed right now. The protection you get from the third (vaccine) is good […]
Pfizer will soon submit data from fourth dose of vaccine to FDA
Updated on 03/09/2022 06:22 am Pfizer Inc. will soon submit data to U.S. regulators on a fourth dose of its COVID-19 vaccine, Chief Executive Officer Albert Bourla said. Bourla said he spent Tuesday morning reviewing new data from several flu vaccine studies. covidincluding one looking at the effects of a fourth dose of the currently […]